Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3 - The American Journal of Geriatric Psychiatry
Esketamine may solve depression need, but not be cost-effective - STAT
SPRAVATO™ (esketamine) - Nasal Spray, Now FDA Approved
Study Finds Ketamine Nasal Spray Effective For Treating Depression: What You Should Know
FDA Approves Ketamine-derived Nasal Spray for Depression | Technology Networks
Janssen presents data for its esketamine nasal spray for depression - Pharmaceutical Technology
Janssen's esketamine reduces symptoms in suicidal depression - Pharmaceutical Technology
Nasal spray drug related to ketamine approved by FDA to treat depression
US approves first depression drug in decades | Financial Times
Nasal spray medicine for treatment-resistant depression not recommended by NICE | News and features | News | NICE
What is a Ketamine Nasal Spray? – Cleveland Clinic
Esketamine, New Depression Drug From Johnson & Johnson, Approved by FDA
Caution urged over use of fast-acting version of ketamine for depression
Depression treatment: First-of-its-kind nasal spray Spravato helping treat depression in Australia